
Dharma Therapeutics, Inc. ("Dharma"), a wholly owned subsidiary of Transcu Ltd. of Singapore, is a new biotech company in the Seattle Life Sciences Center focusing on innovative, non-invasive, needle-free delivery of drugs and vaccines through the skin. Using a revolutionary iontophoretic transdermal drug delivery patch developed by Transcu Group, Dharma will develop multiple products in the areas of therapeutics and vaccines.